Liberty Drug Recalls Injectable Due to Sterility Process Deficiencies
Liberty Drug & Surgical is recalling Papaverine/Phentolamine/Atropine/PGE-1 Injectable vials because process deficiencies may have compromised the product's sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable product, which poses a significant risk of serious injury or infection, meeting the criteria for a Severe rating.
Plain-English summary
Liberty Drug & Surgical is recalling 4 vials of Papaverine/Phentolamine/Atropine/PGE-1 Injectable, 9 mg/1 mg/0.1 mg/10 mcg/mL, 2 mL vial, Rx only. The recall is due to process deficiencies observed in sterile ophthalmic and injectable products that could have compromised the sterility of the product.
The affected product is identified by Lot # 05192015@17 with an expiration date of 07/03/15. The product was distributed to physicians, medical facilities, and prescription-specific patients in New Jersey and New York.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Papaverine/Phentolamine/Atropine/PGE-1 Injectable, 9 mg/1 mg/0.1 mg/10 mcg/mL, 2 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ 07928.
- Manufacturer
- Liberty Drug & Surgical
- Category
- Drug — Injectable
- Affected units
- 4
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 05192015@17
- Exp 07/03/15
Distribution
Part of a larger recall action
This product is one of 25 recalled by Liberty Drug & Surgical under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 25 products in this recall →Related recalls
Same manufacturer · Liberty Drug & Surgical
See all →- SevereLiberty Drug Recalls Papaverine Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Doxycycline IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Hydroxocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Dexamethasone Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Doxycycline IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
Same hazard · sterility compromise
See all →- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighMedline Recalls Cataract Convenience Kits Due to Open Sterile Seals
FDA (Devices) · 2026-09-23
- HighMedline Myringotomy Kits Recalled for Potential Sterility Compromise
FDA (Devices) · 2026-09-23
- HighMedline Anesthesia Pain Kits Recalled for Potential Sterility Compromise
FDA (Devices) · 2026-09-23
- HighMaquet Percutaneous Insertion Kit Recalled for Sterile Barrier Integrity Issues
FDA (Devices) · 2026-09-23
Similar recalls
- SevereVitalab Pharmacy Recalls Sterile Injectable Drug Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereMeditech Formula 9 Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2016-04-13
- HighFDA Recalls Papaverine/Phentolamine Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2023-02-01
- HighInjectable Papaverine/Phentolamine Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-11-09
- SevereFDA Recalls Injectable Solution Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereKey Pharmacy Recalls Papaverine/Phentolamine Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24